U.S. GOVERNMENT SIGNS $450 MILLION COVID-19 VACCINE CONTRACT WITH JOHNSON & JOHNSON

The Trump administration has made another move in the race to combat and stop the viral outbreak of COVID-19, also known as the coronavirus, around the globe. The Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) recently signed a deal for a $456 million order with Johnson & Johnson’s Pharmaceuticals arm Janssen. The order has been specified as a “new vaccine asset for 2019 Novel Coronavirus (COVID-19).” It is the largest amount spent on a vaccine project to date by the administration.